Biopreservation Market

Biopreservation Market by Product Type (Equipment, Biopreservation/Cell Culture Media, and Serums), Application (Biobanking, Regenerative Medicine, and Drug Discovery), End-User (Hospitals & Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increase in chronic diseases and cancer cases, expansion of biobanks, growing awareness of stem cell banking, and growing product development activities across the globe.

The biopreservation market was valued at USD 2,755.43 million in 2024, growing at a CAGR of 9.15% during the forecast period from 2025 to 2032 to reach USD 5,524.33 million by 2032. 

The rising prevalence of chronic diseases and cancer has driven increased demand for biopreservation to support research, diagnostics, and therapeutic development. Biobanks are expanding globally to store a wide range of biological samples, including tissues, stem cells, and DNA, thereby facilitating research efforts and clinical trials. Growing awareness of stem cell banking, particularly for the treatment of future medical conditions, is motivating individuals to preserve cord blood and other regenerative materials.

Furthermore, continuous advancements in product development such as innovations in cryopreservation techniques and automated storage systems are enhancing the reliability and widespread adoption of biopreservation technologies. These technological improvements ensure more effective storage, preservation, and retrieval of biological specimens, contributing to improved research outcomes and clinical applications.

Collectively, these factors are driving the growing need for robust storage solutions, propelling the overall biopreservation market during the forecast period from 2025 to 2032.

Biopreservation Market Dynamics:

According to recent data from GLOBOCAN (2024), an estimated 20 million new cancer cases were reported globally in 2022, with projections indicating an increase to 32.6 million by 2045. As cancer treatments evolve, there is a growing need to store biological samples such as tumor tissues, blood, plasma, and immune cells for research and personalized therapies. Biopreservation enables the long-term storage of these samples while maintaining their viability and integrity, which is essential for future analysis and the development of precision medicine approaches, including targeted therapies.

The rise of immunotherapy, which relies on preserved immune cells like CAR-T cells, further underscores the demand for reliable preservation technologies. Additionally, the expansion of clinical trials for novel cancer treatments drives the market, as preserved samples are crucial for studying biomarkers and evaluating treatment efficacy over time.

The growing number of biobanks and heightened awareness of stem cell banking are also significantly boosting the global biopreservation market. Biobanks serve as essential repositories for biological samples, supporting extensive research in genomics, personalized medicine, and regenerative therapies. As the number of biobanks increases, so does the capacity for long-term storage and management of biological specimens, which is vital for advancing scientific research and clinical applications. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service, providing researchers with access to high-quality tissue samples. This initiative highlights the commitment to improving biobanking capabilities and supporting various research projects.

Simultaneously, growing awareness of stem cell banking driven by advancements in regenerative medicine and the potential of stem cells to treat chronic diseases is encouraging individuals to preserve their stem cells for future therapeutic use. This trend has increased the demand for effective biopreservation techniques. Companies like BioLife Solutions have been pivotal in this space, with their CryoStor freeze media widely used for preserving stem cells and other biological materials. In April 2021, BioLife Solutions further strengthened its product offerings by launching a new high-capacity controlled freezer specifically designed for cell and gene therapy applications.

Despite these growth drivers, certain challenges may hinder the market. Biopreserved materials are highly sensitive to temperature fluctuations, necessitating strict monitoring and specialized cold chain logistics. Any deviation from optimal storage conditions can lead to sample degradation, posing risks to research and therapeutic outcomes. Additionally, compliance with stringent regulatory guidelines such as current Good Manufacturing Practices (cGMP) enforced by agencies like the FDA and EMA can present operational challenges, potentially slowing market growth.

Nevertheless, the collective impact of rising cancer prevalence, expanding biobank infrastructure, growing stem cell awareness, and continuous technological advancements is expected to drive significant growth in the global biopreservation market during the forecast period from 2025 to 2032.

Biopreservation Market Segment Analysis:

Biopreservation Market by Product Type (Equipment, Biopreservation/Cell Culture Media, and Serums), Application (Biobanking, Regenerative Medicine, and Drug Discovery), End-User (Hospitals & Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)  

In the product type segment of the biopreservation market, the biopreservation/cell culture media category is projected to capture a significant revenue share in 2024. This growth is closely linked to the increasing adoption of advanced cell culture media, which are essential for various applications, including regenerative medicine, immunotherapies, and stem cell research. Cell culture media play a pivotal role in providing optimal environments that promote cell viability and proliferation, thereby ensuring the effective preservation of biologically sensitive materials. The synergy between biopreservation technologies and media development is a key driver of market expansion.

A major contributing factor to this growth is the rising demand for serum-free and chemically defined media. Traditional fetal bovine serum (FBS)-based media are being phased out due to ethical concerns, batch variability, and risks of contamination. The shift toward serum-free solutions ensures greater consistency and aligns with stringent regulatory requirements, particularly for biopharmaceutical products like monoclonal antibodies and gene therapies.

Recent market activities highlight how innovations in media formulations are enhancing biopreservation capabilities. For example, BioLife Solutions offers specialized biopreservation media designed to maintain the viability of stem cells and tissues during storage and transport. The integration of cell culture media with biopreservation technologies addresses logistical challenges, allowing biological materials to remain viable for extended periods even under extreme conditions. In September 2024, Merck, a global leader in science and technology, received EXCiPACT cGMP (current Good Manufacturing Practice) certification for Pharmaceutical Auxiliary Materials (PAMs) at its major global Cell Culture Media (CCM) production sites, underscoring the industry’s commitment to high-quality standards.

These factors are expected to drive significant growth in the biopreservation/cell culture media segment, thereby contributing to the overall expansion of the global biopreservation market.

North America is expected to dominate the overall biopreservation market:

Among all regions, North America is projected to hold the largest share of the biopreservation market in 2024. This dominance is driven by a well-established healthcare infrastructure, a high prevalence of chronic diseases and cancer, and significant investments in biobanking and regenerative medicine. The presence of key market players further strengthens the regional market. Additionally, increasing awareness of stem cell banking, government support for advanced research initiatives, and the rising number of clinical trials focused on cell-based therapies are contributing to market growth. The demand for biopreservation technologies is also being fueled by the region's emphasis on personalized medicine and advancements in organ transplantation and immunotherapy.

According to recent data from GLOBOCAN (2024), the estimated number of new cancer cases in North America was 2.67 million in 2022, with projections indicating an increase to 3.83 million by 2045. The rising incidence of cancer is driving the demand for biopreservation technologies, as research and treatment increasingly rely on storing biological samples such as tissues, blood, and DNA. Biopreservation ensures the integrity of these samples for diagnostics, biomarker discovery, and the development of personalized medicine, thereby boosting the regional market.

The expansion of biobanks and growing awareness of stem cell banking are significantly propelling the biopreservation market in North America. Biobanks serve as essential repositories for biological samples, enabling extensive research in genomics, personalized medicine, and regenerative therapies. Concurrently, awareness of stem cell banking has surged in recent years, largely due to the success of stem cell therapies in treating conditions like leukemia, spinal cord injuries, and degenerative diseases. This growing recognition has led to increased demand for stem cell banking services. For instance, according to the Regulatory Affairs Professionals Society (RAPS) in March 2021, 1,480 U.S. businesses were operating 2,754 clinics directly marketing stem cell therapies, reflecting heightened public interest and acceptance.

The combined effects of expanding biobank infrastructures and rising awareness of stem cell banking are driving significant growth in the North American biopreservation market. As more individuals opt to preserve their stem cells and as institutions continue to invest in biobanking capabilities, the demand for effective biopreservation solutions is expected to intensify. This trend is further bolstered by supportive government policies and ongoing advancements in regenerative medicine, positioning North America as a leader in biopreservation practices that cater to both research and patient care needs.

Thus, the above-mentioned factors are expected to accelerate the growth of the biopreservation market in the region.

Biopreservation Market Key Players:

Some of the key market players operating in the biopreservation market include BioLife Solutions, Cell Applications, HiMedia Laboratories, Merck KGaA, Thermo Fisher Scientific, United States Biological, ZenBio, OriGen, SCTbio, Azenta US, Inc., LabVantage Solutions Inc., Hamad Medical Corporation, OriGen Biomedical, STEMCELL Technologies, Cryoport, Inc. and others.

Recent Developmental Activities in the Biopreservation Market:

• In November 2023, BioLife Solutions announced that it has raised USD 10.4 million through private placement by Casdin Capital to support ongoing operations related to biopreservation media and other offerings.
• In February 2022, OriGen received CE mark approval for the CryoStore™ FLEX Freezing Bag product line. Additionally, the company announced the global launch of the CryoStore™ FLEX freezing bag. 
• In June 2023, SCTbio collaborated with Cyto-carein to improve the quality of cryopreservation for cell therapy manufacturing development in Europe.

Key Takeaways From the Biopreservation Market Report Study

• Market size analysis for current biopreservation size (2024), and market forecast for 8 years (2025 to 2032)
•  Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the biopreservation market.
• Various opportunities available for the other competitors in the biopreservation market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current biopreservation market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for biopreservation market growth in the coming future?

Target Audience Who Can be Benefited From This Biopreservation Market Report Study

• Biopreservation product providers
• Research organizations and consulting companies 
• Biopreservation-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in biopreservation 
• Various end-users who want to know more about the biopreservation market and the latest technological developments in the biopreservation market.  

Frequently Asked Questions for the Biopreservation Market:

1. What is biopreservation?

• Biopreservation refers to the process of preserving biological samples—such as cells, tissues, organs, or other biomaterials—under optimal conditions to maintain their viability and functionality for future use. It involves techniques like cryopreservation, refrigeration, and the use of specialized media to ensure long-term storage without compromising sample quality, essential in areas such as regenerative medicine, biobanking, and cell-based therapies.

2. What is the market for biopreservation?

• The biopreservation market was valued at USD 2,755.43 million in 2024, growing at a CAGR of 9.15% during the forecast period from 2025 to 2032 to reach USD 5,524.33 million by 2032. 

3. What are the drivers for the global biopreservation market?

• The rise in chronic diseases and cancer cases has fueled the demand for biopreservation to support research, diagnostics, and therapeutic development. Biobanks are expanding globally to store biological samples like tissues, stem cells, and DNA, aiding research efforts and clinical trials. Growing awareness of stem cell banking, especially for treating future medical conditions, is encouraging individuals to preserve cord blood and other regenerative materials. Additionally, continuous product development activities, including advancements in cryopreservation techniques and automated storage systems, are enhancing the reliability and adoption of biopreservation technologies worldwide. These factors collectively contribute to the increasing need for effective storage solutions, boosting the overall market of biopreservation during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global biopreservation market?

• Some of the key market players operating in the biopreservation are BioLife Solutions, Cell Applications, HiMedia Laboratories, Merck KGaA, Thermo Fisher Scientific, United States Biological, ZenBio, OriGen, SCTbio, Azenta US, Inc., LabVantage Solutions Inc., Hamad Medical Corporation, OriGen Biomedical, STEMCELL Technologies, Cryoport, Inc., and others.

5. Which region has the highest share in the global biopreservation market?

• Among all the regions, North America is expected to hold the largest share of the biopreservation market in 2024. The region has a well-established healthcare infrastructure, a high prevalence of chronic diseases and cancer, and significant investments in biobanking and regenerative medicine. The presence of key market players further strengthens the market. Additionally, increasing awareness of stem cell banking, government support for advanced research initiatives, and a growing number of clinical trials focused on cell-based therapies contribute to market expansion. The demand for biopreservation technologies is also rising due to the region's focus on personalized medicine and advancements in organ transplantation and immunotherapy.